Pharmacokinetic Dashboard-Recommended Dosing Is Different than Standard of Care Dosing in Infliximab-Treated Pediatric IBD Patients
Crossref DOI link: https://doi.org/10.1208/s12248-016-9994-y
Published Online: 2016-10-13
Published Print: 2017-01
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Dubinsky, Marla C.
Phan, Becky L.
Singh, Namita
Rabizadeh, Shervin
Mould, Diane R.
License valid from 2016-10-13